tredenwater2
4 minutes ago
Hosai these conferences, aside from the investment ones, appear to be advertising our drug ahead of approval. A form of “ Ensuring Pre-Launch Readiness in the Alzheimer’s Treatment Landscape" to Dr.’s and medical groups who will be responsible for prescribing Blarcasamine, or whatever the new name w